No evidence of an increased cancer risk with MS interferon..

[MSUK]

No evidence of an increased cancer risk with MS interferon treatment

Assessment of cancer risk with β-interferon treatment for multiple sclerosis.

OBJECTIVE: The risk of cancer after exposure to the β-interferons (IFNβs) for multiple sclerosis (MS) has not been established. We assessed whether IFNβ treatment for MS is associated with cancer risk or the risk of specific cancers in a population-based observational study..... Read More - http://www.ms-uk.org/cancer